Absorption of short wavelengths of endoillumination in indocyanine green solution: implications for internal limiting membrane removal
- PMID: 12719989
- DOI: 10.1007/s00417-003-0636-6
Absorption of short wavelengths of endoillumination in indocyanine green solution: implications for internal limiting membrane removal
Abstract
Purpose: To measure the absorption coefficients of short wavelengths, irradiated by a light source used for vitreous surgery, in indocyanine green (ICG) solution and balanced salt solution (BSS), and to determine the implications of these absorption coefficients on retinal phototoxicity caused by ICG-assisted internal limiting membrane removal.
Methods: The absorption coefficients of short wavelengths irradiated by a commercially available light source used for vitreous surgery were measured in ICG solution and BSS using a dual-beam spectroradiometer.
Results: The absorption coefficient of wavelengths irradiated by the endoillumination light source in ICG solution was almost the same as that obtained in BSS. The absorbance coefficients of the ICG solutions were 0.18 cm(-1) at 400 nm and 0.03 cm(-1) at 450 nm. In BSS, the absorption coefficients were 0.17 cm(-1) at 400 nm and 0.015 cm(-1) at 450 nm. No significant difference in absorbance was seen between 400 nm and 450 nm ( P>0.05).
Conclusions: The absorption of wavelengths is not greater in ICG solution than in BSS. ICG solution during intravitreal use probably does not enhance retinal photochemical injury during ICG-assisted internal limiting membrane removal.
Comment in
-
Indocyanine green-assisted vitreomacular surgery: adverse effects.Graefes Arch Clin Exp Ophthalmol. 2003 Nov;241(11):958; author reply 959-90. doi: 10.1007/s00417-003-0737-2. Epub 2003 Sep 2. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 14652766 No abstract available.
Similar articles
-
Light absorbing properties of indocyanine green (ICG) in solution and after adsorption to the retinal surface: an ex-vivo approach.Graefes Arch Clin Exp Ophthalmol. 2006 Sep;244(9):1196-202. doi: 10.1007/s00417-005-0216-z. Epub 2006 Feb 28. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16518658
-
Light-absorbing properties and osmolarity of indocyanine-green depending on concentration and solvent medium.Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2722-9. doi: 10.1167/iovs.02-1283. Invest Ophthalmol Vis Sci. 2003. PMID: 12766079
-
Biochemical analysis and decomposition products of indocyanine green in relation to solvents, dye concentrations and laser exposure.Ophthalmologica. 2013;230 Suppl 2:59-67. doi: 10.1159/000353871. Epub 2013 Sep 6. Ophthalmologica. 2013. PMID: 24022720
-
Mechanisms of intravitreal toxicity of indocyanine green dye: implications for chromovitrectomy.Retina. 2007 Sep;27(7):958-70. doi: 10.1097/01.iae.0000253051.01194.ab. Retina. 2007. PMID: 17891024 Review.
-
Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety.Eye (Lond). 2009 Mar;23(3):504-18. doi: 10.1038/eye.2008.249. Epub 2008 Aug 1. Eye (Lond). 2009. PMID: 18670454 Review.
Cited by
-
Modified technique for safer indocyanine-green-assisted peeling of the internal limiting membrane during vitrectomy for macular hole repair.Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1615-9. doi: 10.1007/s00417-006-0316-4. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16705449
-
In vivo biocompatibility of a new cyanine dye for ILM peeling.Eye (Lond). 2015 Mar;29(3):428-35. doi: 10.1038/eye.2014.295. Epub 2014 Dec 19. Eye (Lond). 2015. PMID: 25523205 Free PMC article.
-
Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium.Graefes Arch Clin Exp Ophthalmol. 2005 Sep;243(9):917-25. doi: 10.1007/s00417-004-1121-6. Epub 2005 Apr 15. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15834606
-
Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial.Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):973-9. doi: 10.1007/s00417-006-0485-1. Epub 2006 Dec 21. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17186261 Clinical Trial.
-
Indocyanine green-assisted vitreomacular surgery: adverse effects.Graefes Arch Clin Exp Ophthalmol. 2003 Nov;241(11):958; author reply 959-90. doi: 10.1007/s00417-003-0737-2. Epub 2003 Sep 2. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 14652766 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources